News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,225 Results
Type
Article (88899)
Company Profile (724)
Press Release (795581)
Multimedia
Podcasts (243)
Webinars (36)
Section
Business (233643)
Career Advice (4164)
Deals (40016)
Drug Delivery (181)
Drug Development (91764)
Employer Resources (207)
FDA (18587)
Job Trends (17495)
News (398851)
Policy (40021)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (42)
Allergies (210)
Alliances (56990)
ALS (242)
Alzheimer's disease (1991)
Antibody-drug conjugate (ADC) (578)
Approvals (18974)
Artificial intelligence (903)
ASCO (345)
Autoimmune disease (380)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (76)
BIOSECURE Act (23)
Biosimilars (256)
Biotechnology (432)
Bladder cancer (215)
Brain cancer (86)
Breast cancer (855)
Cancer (6744)
Cardiovascular disease (568)
Career advice (3601)
Career pathing (53)
CAR-T (392)
CDC (77)
Celiac Disease (3)
Cell therapy (1099)
Cervical cancer (58)
Clinical research (79299)
Collaboration (2440)
Commercialization (1)
Company closure (8)
Compensation (1550)
Complete response letters (109)
COVID-19 (3044)
CRISPR (128)
C-suite (1338)
Cystic fibrosis (168)
Data (8915)
Decentralized trials (3)
Denatured (93)
Depression (201)
Dermatology (101)
Diabetes (721)
Diagnostics (7630)
Digital health (72)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (457)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (330)
Earnings (102542)
Editorial (80)
Employer branding (25)
Employer resources (177)
Events (138922)
Executive appointments (1220)
FDA (22812)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (2008)
Gene editing (279)
Generative AI (92)
Gene therapy (867)
GLP-1 (1295)
Government (5570)
Grass and pollen (8)
Guidances (426)
Healthcare (21271)
Hematology (198)
HIV (100)
Huntington's disease (69)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (117)
Immunology and inflammation (365)
Immuno-oncology (120)
Indications (225)
Infectious disease (3452)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (332)
Interviews (822)
IPO (18009)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (694)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (888)
Lymphoma (488)
Machine learning (70)
Management (68)
Manufacturing (1284)
Marketing (4)
MASH (229)
Medical affairs (1)
Medical device (15302)
Medtech (15485)
Mergers & acquisitions (23345)
Metabolic disorders (1861)
mRNA (275)
Multiple sclerosis (211)
NASH (24)
Neurodegenerative disease (525)
Neuropsychiatric disorders (132)
Neuroscience (3794)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5147)
Now hiring (84)
Obesity (885)
Opinion (380)
Ovarian cancer (251)
Pain (289)
Pancreatic cancer (373)
Parkinson's disease (429)
Partnered (42)
Patents (680)
Patient recruitment (807)
Peanut (72)
People (68151)
Pharmaceutical (115)
Pharmacy benefit managers (38)
Phase 1 (24507)
Phase 2 (34451)
Phase 3 (25900)
Pipeline (10189)
Policy (405)
Postmarket research (3560)
Preclinical (11002)
Press Release (72)
Prostate cancer (354)
Psychedelics (73)
Radiopharmaceuticals (378)
Rare diseases (1322)
Real estate (7462)
Recruiting (82)
Regulatory (30612)
Reports (77)
Research institute (2775)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (197)
Series A (344)
Series B (250)
Service/supplier (24)
Sickle cell disease (132)
Special edition (33)
Spinal muscular atrophy (191)
Sponsored (55)
Startups (4375)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (147)
Vaccines (1331)
Venture capital (142)
Weight loss (604)
Women's health (147)
Worklife (25)
Date
Today (114)
Last 7 days (558)
Last 30 days (2549)
Last 365 days (33170)
2026 (17681)
2025 (33217)
2024 (38031)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (101)
Alaska (7)
Arizona (409)
Arkansas (16)
Asia (52405)
Australia (9209)
California (14617)
Canada (4102)
China (1629)
Colorado (629)
Connecticut (649)
Delaware (452)
Europe (120854)
Florida (2190)
Georgia (474)
Hawaii (4)
Idaho (70)
Illinois (1284)
India (107)
Indiana (673)
Iowa (27)
Japan (623)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1764)
Massachusetts (10712)
Michigan (428)
Minnesota (817)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (156)
New Hampshire (92)
New Jersey (3875)
New Mexico (35)
New York (3862)
North Carolina (1957)
North Dakota (11)
Northern California (7293)
Ohio (458)
Oklahoma (27)
Oregon (55)
Pennsylvania (2872)
Puerto Rico (33)
Rhode Island (55)
South America (1669)
South Carolina (89)
South Dakota (2)
Southern California (5751)
Tennessee (240)
Texas (2390)
United States (52320)
Utah (437)
Vermont (2)
Virginia (377)
Washington D.C. (89)
Washington State (1195)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
There are 885,225 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fosun International Garners Five Awards from Corporate Governance Asia
July 2, 2026
·
8 min read
Approvals
Vertex’s Casgevy becomes first approved gene therapy for young kids with rare blood disorders
The FDA approved the expansion of Casgevy, which had previously been greenlit for patients 12 and up, into a younger pediatric population under the agency’s Commissioner’s National Priority Voucher program.
July 2, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
July 2, 2026
·
8 min read
Job Trends
8 companies hiring in Greater Philadelphia
Looking for your next role in Philly? Here are 8 companies currently hiring.
July 2, 2026
·
1 min read
·
Chantal Dresner
Press Releases
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
July 2, 2026
·
11 min read
Press Releases
Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery
July 1, 2026
·
3 min read
Press Releases
Otsuka Reports Positive Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Prevented Progression to Kidney Failure and Improved Kidney Function in IgA Nephropathy (IgAN)
July 1, 2026
·
11 min read
Press Releases
FDA Alignment to Advance ProstACT Global Phase 3 Trial
July 1, 2026
·
8 min read
Press Releases
Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases
July 1, 2026
·
4 min read
Press Releases
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
July 1, 2026
·
4 min read
1 of 88,523
Next
